:


Druker BJ, et al. Efficacy and safety of a specific inhibitor of the Bcr-Abl tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001; 344:1031.

Druker BJ, et al. Activity of a specific inhibitor of the Bcr-Abl tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chomosome. N Engl J Med 2001; 344:1038.

Goldman JM, Druker BJ. Chronic myeloid leukemia: current treatment options. Blood 2001; 98:2039.

Kantaijian H, et al. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N Engl J Med 2002; 346:645.

Weisdorf DJ, et al. Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donors. Blood 2002; 99:1971.

:

  • ( , , CML)